Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Age at First Osteoporosis Screening Among Older Women and Men: Is Bone Mineral Density Measurement Ordered Timely?

Author(s): Ilker Tasci*, Bilgin Bahadir Basgoz, Umit Cintosun, Umut Safer and Mehmet Ilkin Naharci

Volume 19, Issue 4, 2019

Page: [534 - 540] Pages: 7

DOI: 10.2174/1871530319666181226125756

Price: $65

Abstract

Background: US National Osteoporosis Foundation has specified age cut-offs for osteoporosis screening in older women and men.

Objective: In this study, we investigated whether Turkish seniors undergo their first ever osteoporosis screening early, on time or late.

Methods: We determined the age of older women and men at their first-time Bone Mass Densitometry (BMD) testing using the medical records of a geriatric outpatient unit. The timing of the BMD test was considered ‘’late’’ when performed after the age of 65 and 70 in women and men, respectively. An “early” screening was defined as having a BMD measurement before these age cut-offs.

Results: We included 481 individuals in the study (mean age: 74.5±6.5 years, women: 62%). On admission, around 18% of the sample could give no definite information and another 35% had never been assessed for osteoporosis. Among those with a past screening, 64.8% reported comorbid osteoporosis and 33% reported no osteoporosis. Mean age of the first-time BMD measurement was 67.4±7.7 years. The first-time BMD measurement was on time in 9.7%, early in 37.4% and late in 52.9% of the subjects. Half of the individuals with a self-reported osteoporosis diagnosis were non-osteoporotic on a new BMD ordered following the geriatric assessment. Multimorbidity (≥3), parental hip fracture, and smoking were the independent predictors of being early screened.

Conclusion: We found two-thirds of women and men unscreened for osteoporosis despite being indicated by age. Early and late screening were both prevalent. Self-reported osteoporosis diagnosis was mostly inconsistent with BMD testing in our sample.

Keywords: Osteoporosis, screening, elderly, bone mineral density, DEXA, comprehensive geriatric assessment.

« Previous Next »
Graphical Abstract

[1]
Wade, S.W.; Strader, C.; Fitzpatrick, L.A.; Anthony, M.S.; O’Malley, C.D. Estimating prevalence of osteoporosis: Examples from industrialized countries. Arch. Osteoporos., 2014, 9, 182.
[2]
Nelson, H.D.; Haney, E.M.; Chou, R.; Dana, T.; Fu, R.; Bougatsos, C.U.S. Preventive services task force evidence syntheses, formerly systematic evidence reviews. In: Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation; Agency for Healthcare Research and Quality (US): Rockville (MD), 2010.
[3]
Cauley, J.A.; Thompson, D.E.; Ensrud, K.C.; Scott, J.C.; Black, D. Risk of mortality following clinical fractures. Osteoporos. Int., 2000, 11(7), 556-561.
[4]
Center, J.R.; Nguyen, T.V.; Schneider, D.; Sambrook, P.N.; Eisman, J.A. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet, 1999, 353(9156), 878-882.
[5]
Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann. Intern. Med., 2011, 154(5), 356-364.
[6]
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA, 2001, 285(6), 785-795.
[7]
Camacho, P.M.; Petak, S.M.; Binkley, N.; Clarke, B.L.; Harris, S.T.; Hurley, D.L.; Kleerekoper, M.; Lewiecki, E.M.; Miller, P.D.; Narula, H.S.; Pessah-Pollack, R.; Tangpricha, V.; Wimalawansa, S.J.; Watts, N.B. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016--executive summary. Endocr. Pract., 2016, 22(9), 1111-1118.
[8]
Qaseem, A.; Snow, V.; Shekelle, P.; Hopkins, R., Jr; Forciea, M.A.; Owens, D.K. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med., 2008, 148(9), 680-684.
[9]
Cosman, F.; de Beur, S.J.; LeBoff, M.S.; Lewiecki, E.M.; Tanner, B.; Randall, S.; Lindsay, R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos. Int., 2014, 25(10), 2359-2381.
[10]
Kanis, J.A.; Johnell, O.; Oden, A.; Johansson, H.; McCloskey, E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int., 2008, 19(4), 385-397.
[11]
Tasci, I.; Cintosun, U.; Safer, U.; Naharci, M.I.; Bozoglu, E.; Aydogdu, A.; Doruk, H. Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: A prospective follow-up study. Acta Clin. Belg., 2017, 73(4), 237-243.
[12]
Tasci, I.; Safer, U.; Cintosun, U.; Bozoglu, E.; Naharci, I.; Aydogdu, A.; Meric, C.; Doruk, H. Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis. Endocr. Metab. Immune Disord. Drug Targets, 2016, 16(1), 32-38.
[13]
Watts, N.B.; Lewiecki, E.M.; Miller, P.D.; Baim, S. National Osteoporosis Foundation 2008 Clinician’s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J. Clin. Densitom., 2008, 11(4), 473-477.
[14]
Schuit, S.C.; van der Klift, M.; Weel, A.E.; de Laet, C.E.; Burger, H.; Seeman, E.; Hofman, A.; Uitterlinden, A.G.; van Leeuwen, J.P.; Pols, H.A. Fracture incidence and association with bone mineral density in elderly men and women: The rotterdam study. Bone, 2004, 34(1), 195-202.
[15]
Solomon, D.H.; Connelly, M.T.; Rosen, C.J.; Dawson-Hughes, B.; Kiel, D.P.; Greenspan, S.L.; Leib, E.S.; Holick, M.; Miguel, A.H.; Finkelstein, J.S. Factors related to the use of bone densitometry: Survey responses of 494 primary care physicians in New England. Osteoporos. Int., 2003, 14(2), 123-129.
[16]
Cheng, N.; Green, M.E. Osteoporosis screening for men: are family physicians following the guidelines? Can. Fam. Physician, 2008, 54(8), 1140-1141.
[17]
Ioannidis, G.; Papaioannou, A.; Thabane, L.; Gafni, A.; Hodsman, A.; Kvern, B.; Walsh, A.; Jiwa, F.; Adachi, J.D. Family physicians’ personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing. Popul. Health Manag., 2009, 12(3), 131-138.
[18]
Fogelman, Y.; Goldshtein, I.; Segal, E.; Ish-Shalom, S. Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel. PLoS One, 2016, 11(8)e0160661
[19]
Choi, Y.J.; Oh, H.J.; Kim, D.J.; Lee, Y.; Chung, Y.S. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: The Korea national health and nutrition examination survey 2008-2009. J. Bone Miner. Res., 2012, 27(9), 1879-1886.
[20]
Weng, W.; Hess, B.J.; Lynn, L.A.; Lipner, R.S. Assessing the Quality of Osteoporosis Care in Practice. J. Gen. Intern. Med., 2015, 30(11), 1681-1687.
[21]
Tuzun, S.; Eskiyurt, N.; Akarirmak, U.; Saridogan, M.; Senocak, M.; Johansson, H.; Kanis, J.A. Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos. Int., 2012, 23(3), 949-955.
[22]
Olomu, A.B.; Corser, W.D.; Stommel, M.; Xie, Y.; Holmes-Rovner, M. Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly? BMC Health Serv. Res., 2012, 12(1), 398.
[23]
Kriegsman, D.M.; Penninx, B.W.; van Eijk, J.T.; Boeke, A.J.; Deeg, D.J. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients’ self-reports and on determinants of inaccuracy. J. Clin. Epidemiol., 1996, 49(12), 1407-1417.
[24]
Stuart, A.L.; Williams, L.J.; Brennan, S.L.; Kotowicz, M.A.; Pasco, J.A. Poor agreement between self-reported diagnosis and bone mineral density results in the identification of osteoporosis. J. Clin. Densitom., 2015, 18(1), 13-16.
[25]
Chen, Z.; Kooperberg, C.; Pettinger, M.B.; Bassford, T.; Cauley, J.A.; LaCroix, A.Z.; Lewis, C.E.; Kipersztok, S.; Borne, C.; Jackson, R.D. Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause, 2004, 11(3), 264-274.
[26]
Rothmann, M.J.; Ammentorp, J.; Bech, M.; Gram, J.; Rasmussen, O.W.; Barkmann, R.; Glüer, C.C.; Hermann, A.P. Self-perceived facture risk: factors underlying women’s perception of risk for osteoporotic fractures: The Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE). Osteoporos. Int., 2015, 26(2), 689-697.
[27]
Wenger, N.S.; Solomon, D.H.; Roth, C.P.; MacLean, C.H.; Saliba, D.; Kamberg, C.J.; Rubenstein, L.Z.; Young, R.T.; Sloss, E.M.; Louie, R.; Adams, J.; Chang, J.T.; Venus, P.J.; Schnelle, J.F.; Shekelle, P.G. The quality of medical care provided to vulnerable community-dwelling older patients. Ann. Intern. Med., 2003, 139(9), 740-747.
[28]
Greenspan, S.L.; Perera, S.; Ferchak, M.A.; Nace, D.A.; Resnick, N.M. Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern. Med., 2015, 175(6), 913-921.
[29]
Teng, G.G.; Curtis, J.R.; Saag, K.G. Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job? Curr. Osteoporos. Rep., 2009, 7(1), 27-34.

Rights & Permissions Print Cite
Article Metrics
26
2
© 2024 Bentham Science Publishers | Privacy Policy